The Shizuoka Cohort Study of Ovarian Cancer Screening (SCSOCS) recruited asymptomatic postmenopausal women for annual transvaginal ultrasound and CA125 (intervention group n = 41,688 vs. control group n = 40,799). The gene discussed is MUC16; the disease is ovarian cancer.